ACELARATE

Trial description
A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with Gemcitabine in patients with metastatic pancreatic carcinoma
Contact name
Dr Pippa Corrie
Trial start date
Monday, March 14, 2016
Trial end date
Thursday, March 14, 2019
Trial tumour type
Pancreatic
Show on Radiotherapy
No